Smooth muscle Insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in neonatal mice

Miranda Sun, Ramaswamy Ramchandran, Jiwang Chen, Qiwei Yang, J. Usha Raj

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Insulin-like growth factor (IGF)-1 is a potent mitogen of vascular smooth muscle cells (SMCs), but its role in pulmonary vascular remodeling associated with pulmonary hypertension (PH) is not clear. In an earlier study, we implicated IGF-1 in the pathogenesis of hypoxia-inducedPHin neonatal mice. In this study, we hypothesized that hypoxia-induced up-regulation of IGF-1 in vascular smooth muscle is directly responsible for pulmonary vascular remodeling and PH. We studied neonatal and adult mice with smooth muscle-specific deletion of IGF-1 and also used an inhibitor of IGF-1 receptor (IGF-1R), OSI-906, in neonatal mice. We found that, in neonatal mice, SMC-specific deletion of IGF-1 or IGF-1R inhibition with OSI-906 attenuated hypoxia-induced pulmonary vascular remodeling in small arteries, right ventricular hypertrophy, and right ventricular systolic pressure. Pulmonary arterial SMCs from IGF-1-deleted mice or after OSI-906 treatment exhibited reduced proliferative potential. However, in adult mice, smooth muscle-specific deletion of IGF-1 had no effect on hypoxia-induced PH. Our data suggest that vascular smooth muscle-derived IGF-1 plays a critical role in hypoxia-inducedPHin neonatal mice but not in adult mice. We speculate that the IGF-1/IGF-1R axis is important in pathogenesis of PH in the developing lung and may be amenable to therapeutic manipulation in this age group.

Original languageEnglish (US)
Pages (from-to)779-791
Number of pages13
JournalAmerican journal of respiratory cell and molecular biology
Volume55
Issue number6
DOIs
StatePublished - Dec 2016

Fingerprint

Somatomedins
Pulmonary Hypertension
Smooth Muscle
Muscle
Lung
Vascular Smooth Muscle
Smooth Muscle Myocytes
Hypoxia
Right Ventricular Hypertrophy
Somatomedin Receptors
Ventricular Pressure
Mitogens
Up-Regulation
Arteries
Age Groups
Blood Pressure
Cells

Keywords

  • Hypoxia
  • Insulin-like growth factor
  • Neonatal
  • Pulmonary hypertension
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Smooth muscle Insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in neonatal mice. / Sun, Miranda; Ramchandran, Ramaswamy; Chen, Jiwang; Yang, Qiwei; Raj, J. Usha.

In: American journal of respiratory cell and molecular biology, Vol. 55, No. 6, 12.2016, p. 779-791.

Research output: Contribution to journalArticle

Sun, Miranda ; Ramchandran, Ramaswamy ; Chen, Jiwang ; Yang, Qiwei ; Raj, J. Usha. / Smooth muscle Insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in neonatal mice. In: American journal of respiratory cell and molecular biology. 2016 ; Vol. 55, No. 6. pp. 779-791.
@article{2d09c32021cf492eb885e3c27957f9c9,
title = "Smooth muscle Insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in neonatal mice",
abstract = "Insulin-like growth factor (IGF)-1 is a potent mitogen of vascular smooth muscle cells (SMCs), but its role in pulmonary vascular remodeling associated with pulmonary hypertension (PH) is not clear. In an earlier study, we implicated IGF-1 in the pathogenesis of hypoxia-inducedPHin neonatal mice. In this study, we hypothesized that hypoxia-induced up-regulation of IGF-1 in vascular smooth muscle is directly responsible for pulmonary vascular remodeling and PH. We studied neonatal and adult mice with smooth muscle-specific deletion of IGF-1 and also used an inhibitor of IGF-1 receptor (IGF-1R), OSI-906, in neonatal mice. We found that, in neonatal mice, SMC-specific deletion of IGF-1 or IGF-1R inhibition with OSI-906 attenuated hypoxia-induced pulmonary vascular remodeling in small arteries, right ventricular hypertrophy, and right ventricular systolic pressure. Pulmonary arterial SMCs from IGF-1-deleted mice or after OSI-906 treatment exhibited reduced proliferative potential. However, in adult mice, smooth muscle-specific deletion of IGF-1 had no effect on hypoxia-induced PH. Our data suggest that vascular smooth muscle-derived IGF-1 plays a critical role in hypoxia-inducedPHin neonatal mice but not in adult mice. We speculate that the IGF-1/IGF-1R axis is important in pathogenesis of PH in the developing lung and may be amenable to therapeutic manipulation in this age group.",
keywords = "Hypoxia, Insulin-like growth factor, Neonatal, Pulmonary hypertension, Vascular smooth muscle",
author = "Miranda Sun and Ramaswamy Ramchandran and Jiwang Chen and Qiwei Yang and Raj, {J. Usha}",
year = "2016",
month = "12",
doi = "10.1165/rcmb.2015-0388OC",
language = "English (US)",
volume = "55",
pages = "779--791",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Smooth muscle Insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in neonatal mice

AU - Sun, Miranda

AU - Ramchandran, Ramaswamy

AU - Chen, Jiwang

AU - Yang, Qiwei

AU - Raj, J. Usha

PY - 2016/12

Y1 - 2016/12

N2 - Insulin-like growth factor (IGF)-1 is a potent mitogen of vascular smooth muscle cells (SMCs), but its role in pulmonary vascular remodeling associated with pulmonary hypertension (PH) is not clear. In an earlier study, we implicated IGF-1 in the pathogenesis of hypoxia-inducedPHin neonatal mice. In this study, we hypothesized that hypoxia-induced up-regulation of IGF-1 in vascular smooth muscle is directly responsible for pulmonary vascular remodeling and PH. We studied neonatal and adult mice with smooth muscle-specific deletion of IGF-1 and also used an inhibitor of IGF-1 receptor (IGF-1R), OSI-906, in neonatal mice. We found that, in neonatal mice, SMC-specific deletion of IGF-1 or IGF-1R inhibition with OSI-906 attenuated hypoxia-induced pulmonary vascular remodeling in small arteries, right ventricular hypertrophy, and right ventricular systolic pressure. Pulmonary arterial SMCs from IGF-1-deleted mice or after OSI-906 treatment exhibited reduced proliferative potential. However, in adult mice, smooth muscle-specific deletion of IGF-1 had no effect on hypoxia-induced PH. Our data suggest that vascular smooth muscle-derived IGF-1 plays a critical role in hypoxia-inducedPHin neonatal mice but not in adult mice. We speculate that the IGF-1/IGF-1R axis is important in pathogenesis of PH in the developing lung and may be amenable to therapeutic manipulation in this age group.

AB - Insulin-like growth factor (IGF)-1 is a potent mitogen of vascular smooth muscle cells (SMCs), but its role in pulmonary vascular remodeling associated with pulmonary hypertension (PH) is not clear. In an earlier study, we implicated IGF-1 in the pathogenesis of hypoxia-inducedPHin neonatal mice. In this study, we hypothesized that hypoxia-induced up-regulation of IGF-1 in vascular smooth muscle is directly responsible for pulmonary vascular remodeling and PH. We studied neonatal and adult mice with smooth muscle-specific deletion of IGF-1 and also used an inhibitor of IGF-1 receptor (IGF-1R), OSI-906, in neonatal mice. We found that, in neonatal mice, SMC-specific deletion of IGF-1 or IGF-1R inhibition with OSI-906 attenuated hypoxia-induced pulmonary vascular remodeling in small arteries, right ventricular hypertrophy, and right ventricular systolic pressure. Pulmonary arterial SMCs from IGF-1-deleted mice or after OSI-906 treatment exhibited reduced proliferative potential. However, in adult mice, smooth muscle-specific deletion of IGF-1 had no effect on hypoxia-induced PH. Our data suggest that vascular smooth muscle-derived IGF-1 plays a critical role in hypoxia-inducedPHin neonatal mice but not in adult mice. We speculate that the IGF-1/IGF-1R axis is important in pathogenesis of PH in the developing lung and may be amenable to therapeutic manipulation in this age group.

KW - Hypoxia

KW - Insulin-like growth factor

KW - Neonatal

KW - Pulmonary hypertension

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=85003007718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003007718&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2015-0388OC

DO - 10.1165/rcmb.2015-0388OC

M3 - Article

C2 - 27438786

AN - SCOPUS:85003007718

VL - 55

SP - 779

EP - 791

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 6

ER -